Davide Maria Donati, MD

Photo of Davide Maria Donati MD
Davide Maria Donati, MD
+39-051-6366012
+39-051-3399467

Personal information - Education and work experience

16/07/1958
Associate Professor at the University of Bologna, operating as MD under agreement with the Rizzoli Orthopedic Institute

Temporary assignment as deputy to the Director of the Clinical Orthopaedics and Traumatology III prevalently oncologic.

Simple Structure Laboratory of Orthopaedic Pathology and Osteoarticular Tissue Regeneration.

1983: Degree in Medicine and Surgery from the University of Bologna.

1988: Specialization in Orthopedy.

Affiliated with the Harvard Medical School of Boston, MA, and with the Mayo Clinic, of Rochester, MN, USA.

Excellent English.

Person in charge and collaborator in numerous clinical research internal projects of the Rizzoli Orthopaedic Institute, and in several base research external projects in the laboratory and pre-clinic field.

Oncological research:

  • Development and implantation of tailored prostheses, prototyped by 3D printing;
  • Guided surgery of the pelvis and sacrum in patients with primitive or secondary tumors.

Research in the field of regenerative medicine:

  • Treatment of osteonecrosis with autologous stem cells;
  • Treatment of pseudo-tumoral lesions with stem cells drawn from the bone marrow;
  • Treatment of consolidation delays with stem cells drawn from the marrow;
  • Reconstruction of cartilaginous defects.

Invited as speaker and assistant supervisor to several national and international conventions. Author of over 300 publications, including proceedings of conventions and articles on reviews.

High specialization in the treatment of:

  • Malignant bone e soft tissue tumors: osteosarcoma, Ewing sarcoma, chondrosarcoma, liposarcoma, soft tissue sarcoma etc.;
  • Benignant bone and soft tissue tumors: lipoma, atypical lipomatous tumor, myxoma, chondroma, exostosi, etc.;
  • Pseudo-tumoral lesions: simple bone cyst, aneurismal cyst, fibrous dysplasia;
  • Development of tailored prostheses for the treatment of osteochondral knee lesions;
  • Development of tailored pelvis prostheses for the reconstruction of malignant pelvic lesions.
Content updated 21/12/2016 - 11:55
Utilizza SharethisShareThis  Scrivi una email  Vai a facebook  Vai a twitter